ID   H3677
AC   CVCL_H603
SY   3677
DR   ChEMBL-Cells; CHEMBL3307809
DR   ChEMBL-Targets; CHEMBL612820
DR   PubChem_Cell_line; CVCL_H603
DR   Wikidata; Q54585138
RX   PubMed=7627964;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=7627964;
RA   Kerr D.E., Schreiber G.J., Vrudhula V.M., Svensson H.P., Hellstrom I.,
RA   Hellstrom K.E., Senter P.D.;
RT   "Regressions and cures of melanoma xenografts following treatment with
RT   monoclonal antibody beta-lactamase conjugates in combination with
RT   anticancer prodrugs.";
RL   Cancer Res. 55:3558-3563(1995).
//